Colposcopy Clinical Trial
Official title:
Comparison of Lidocaine Spray With Forced Coughing in Pain Relief During Colposcopy Guided Cervical Biopsy Procedure: A Randomized Controlled Trial
Verified date | March 2018 |
Source | Yuzuncu Yil University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cervical cancer is the third most common genital cancer worldwide. The diagnosis of cervical cancer is performed with the cervical biopsy which is guided by the colposcopy. The colposcopy guided cervical biopsy creates pain and several methods have been reported to overcome the pain related with this procedure. Local anesthetic agent injection into the cervix has been studied and found to be effective and also, forced coughing was compared with local anesthetic injection and it is found to be more effective. In fact local injections can create the pain by itself.However no study compared the effect of forced coughing to local anesthetic spray. The study aims to evaluate the comparison of forced coughing with local anesthetic spray with respect to perceived pain during colposcopy guided biopsy.
Status | Completed |
Enrollment | 96 |
Est. completion date | March 10, 2018 |
Est. primary completion date | March 8, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patients with age >18, - Presence of cervix, - Patients who need a diagnostic work up for abnormal cervical smear results. Exclusion Criteria: - Pregnancy, - Presence of already known invasive cancer, - Allergy to anesthetic agents. |
Country | Name | City | State |
---|---|---|---|
Turkey | Yuzuncu Yil University, Medical faculty, department of obstetric and gynecology | Van |
Lead Sponsor | Collaborator |
---|---|
Yuzuncu Yil University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain during procedure evaluated by the 0-10 cm scale of Visual analog scale (VAS) scoring system | The perceived pain will be measured during the biopsy procedure. It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain'' | 0-1 min | |
Secondary | Pain at the 30th minutes after the procedure evaluated by the 0-10 cm scale of VAS scoring system | The perceived pain will be measured after the biopsy procedure (at the 30th min). It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain'' | 30. Min |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03701347 -
A Comparison of Three Simulators for Colposcopy LEEP Training
|
N/A | |
Withdrawn |
NCT04704011 -
Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial
|
N/A | |
Completed |
NCT00839475 -
Investigation of the Uterine Cervix Using CervicalMD
|
N/A | |
Recruiting |
NCT06149598 -
Coughing at Time of Cervical Biopsy
|
N/A | |
Completed |
NCT01214304 -
Aromatherapy to Reduce Pain and Anxiety During Cervical Colposcopy
|
N/A | |
Completed |
NCT03317470 -
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap
|
Phase 1 | |
Recruiting |
NCT05281939 -
Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images
|
N/A | |
Completed |
NCT00474968 -
Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique.
|
N/A | |
Completed |
NCT00941512 -
High Resolution Digital Imaging of the Uterine Cervix
|
N/A | |
Completed |
NCT03464552 -
Celecoxib in Colposcopic Directed Biopsy
|
Phase 4 |